Multiorgan Manifestation
PTH Deficiency—Systemic Impact That Puts Multiple
Organs at Risk1-3
A range of symptoms and risks are associated with PTH deficiency and conventional therapy1-3
- Seizures
- Basal ganglia calcifications
- Parkinsonism or dystonia
- Cardiac arrhythmias
- Hypocalcemia-associated dilated cardiomyopathy
- Vascular calcifications
- Chronic kidney disease*
- Nephrocalcinosis*
- Nephrolithiasis*
- Myopathy
- Muscle cramps/tetany
- Paresthesia
- Cognitive impairment ("brain fog")
- Symptoms of anxiety and depression
- Reduced bone turnover
- Increased bone density
- Spondyloarthropathy
- Seizures
- Basal ganglia calcifications
- Parkinsonism or dystonia
- Cardiac arrhythmias
- Hypocalcemia-associated dilated cardiomyopathy
- Vascular calcifications
- Myopathy
- Muscle cramps/tetany
- Paresthesia
- Cognitive impairment ("brain fog")
- Symptoms of anxiety and depression
- Chronic kidney disease*
- Nephrocalcinosis*
- Nephrolithiasis*
- Reduced bone turnover
- Increased bone density
- Spondyloarthropathy
| Adapted by permission from Springer Nature. Nature Reviews Disease Primers. 2017;3:17055. Hypoparathyroidism. Mannstadt M, et al. 2017. | |
| * | These manifestations are mostly the result of treatment with pharmacologically high doses of calcium and calcitriol (active vitamin D) rather than of the disease itself.3 |